|
Bobby Sandage is executive vice president, research and development and chief scientific officer of Indevus Pharmaceuticals, Inc. He previously held senior development positions within the cardiovascular research and development division at DuPont Merck Pharmaceutical Company and was affiliated with the Medical Department of DuPont Critical Care, most recently as associate medical director. Dr. Sandage is an adjunct professor in the Department of Pharmacology at the Massachusetts College of Pharmacy. Dr. Sandage received his Ph.D. in Clinical Pharmacy from Purdue University and his B.S. in Pharmacy from the University of Arkansas. | 